# US 2012/0253190 A1 · Contrast-enhanced ultrasound assessment of liver blood flow for monitoring liver therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253190 A1
- Document ID: US20120253190A1
- Status: Published application
- Kind: A1
- Application number: 13/499,383
- Filed: 2010-09-27
- Published: 2012-10-04
- Earliest claimed: 2009-10-01
- Assignees: Koninklijke Philips Electronics N.V.
- Inventors: Thomas Patrice Jean Arsene Gauthier; Edward Lam Shang Leen
- Web page: https://patentgrep.com/patent/US20120253190A1

## CPC

- G06T 7/0016: {involving temporal comparison}
- A61B 8/06: Measuring blood flow
- A61B 8/469: {for selection of a region of interest}
- A61B 8/481: {involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream}
- A61B 8/5223: {for extracting a diagnostic or physiological parameter from medical diagnostic data (for algorithms to analyse biomedical images G06T7/0012)}
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G06T 2207/10132: Ultrasound image
- G06T 2207/30056: Liver; Hepatic
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A method for assessing a liver includes acquiring image information including contrast-enhanced ultrasound images of the liver. A location of the main hepatic artery (MHA) and a location of the main portal vein (MPV) of the liver are identified in at least one of the contrast-enhanced ultrasound images of the liver. Time-intensity information corresponding to perfusion of a contrast agent in the MHA and the MPV is obtained. A biomarker index value (BW) which is a function of the time-intensity information corresponding to the perfusion of contrast agent in the MHA and the time-intensity information corresponding to the perfusion of contrast agent in the MPV is determined.

## Claims

### Claim 1

A method for assessing a condition of a liver, the method comprising:
acquiring image information comprising contrast-enhanced ultrasound images of the liver using an ultrasonic probe;
identifying a location of a main hepatic artery (MHA) and a location of a main portal vein (MPV) of the liver in at least one of the contrast-enhanced ultrasound images of the liver;
obtaining time-intensity information corresponding to a perfusion of a contrast agent in the MHA;
obtaining time-intensity information corresponding to a perfusion of a contrast agent in the MPV;
determining a biomarker index value (BIV) as a function of the time-intensity information corresponding to the perfusion of contrast agent in the MHA and the time-intensity information corresponding to the perfusion of contrast agent in the MPV; and
outputting to an output device an indication of the condition of the liver based on the BIV.

### Claim 2 (depends on 1)

The method of claim 1, wherein the BIV is based upon a ratio of the time-intensity information corresponding to the perfusion of the contrast agent in the MHA to the time-intensity information corresponding to the perfusion of the contrast agent in the MPV.

### Claim 3 (depends on 1)

The method of claim 1, wherein the BIV is defined as:
BIV
=
peak


intensity
×
wash

-

in


slope


(
main


hepatic


artery
)
peak


intensity
×
wash

-

in


slope


(
main


portal


vein
)
where:
wash

-

in


slope
=
peak


itensity
rise


time
of a corresponding MHA and MPV.

### Claim 4 (depends on 1)

The method of claim 1, wherein the act of identifying the location of the MHA and the location of the MPV comprises receiving location information corresponding to the location of the MHA or the MPV from a user via a user interface.

### Claim 5 (depends on 1)

The method of claim 1, wherein the act of identifying the location of the MHA and the location of the MPV is automatically performed by a processor performing image processing of the contrast-enhanced ultrasound images.

### Claim 6 (depends on 1)

The method of claim 1, wherein the time-intensity information is based upon pixel intensity information indicative of each of the perfusion of the contrast agent in the MHA and the perfusion of the contrast agent in the MPV.

### Claim 7 (depends on 1)

The method of claim 1, further comprising an act of introducing the contrast agent into a blood stream of a patient.

### Claim 8

A system for assessing a condition of a liver, the system comprising:
a processor which is configured to:
acquire image information comprising contrast-enhanced ultrasound images of the liver;
identify a location of a main hepatic artery (MHA) and a location of a main portal vein (MPV) of the liver in at least one of the contrast-enhanced ultrasound images of the liver;
obtain time-intensity information corresponding to a perfusion of a contrast agent in the MHA;
obtain time-intensity information corresponding to a perfusion of a contrast agent in the MPV; and
determine a biomarker index value (BIV) as a function of the time-intensity information corresponding to the perfusion of contrast agent in the MHA and the time-intensity information corresponding to the perfusion of contrast agent in the MPV.

### Claim 9 (depends on 8)

The system of claim 8, wherein the processor is further configured to determine the BIV based upon a ratio of the time-intensity information corresponding to the perfusion of the contrast agent in the MHA to the time-intensity information corresponding to the perfusion of the contrast agent in the MPV.

### Claim 10 (depends on 1)

The system of claim 1, wherein the processor determines the BIV using a following equation:
BIV
=
peak


intensity
×
wash

-

in


slope


(
main


hepatic


artery
)
peak


intensity
×
wash

-

in


slope


(
main


portal


vein
)
where:
wash

-

in


slope
=
peak


itensity
rise


time
of a corresponding MHA and MPV.

### Claim 11 (depends on 8)

The system of claim 8, further comprising a user interface which receives location information corresponding to the location of at least one of the MHA and the MPV from a user and forwards the location information to the processor for identifying the location of at least one of the MHA and the MPV based upon the location information.

### Claim 12 (depends on 8)

The system of claim 8, wherein the processor is further configured to perform image processing for identifying the location of at least one of the MHA and the MPV in at least one of the contrast-enhanced ultrasound images of the liver.

### Claim 13 (depends on 8)

The system of claim 8, wherein the processor is further configured to determine the time-intensity information based upon pixel intensity information indicative of the perfusion of the contrast agent in at least one of the MHA and the MPV.

### Claim 14 (depends on 8)

The system of claim 8, further comprising an injection device, wherein the processor is further configured to control the injection device to automatically introduces the contrast agent into a blood stream of a patient.
